RANIVIZ ranibizumab (rbe) 10 mg/mL solution for injection vial

国家: 澳大利亚

语言: 英文

来源: Department of Health (Therapeutic Goods Administration)

有效成分:

Ranibizumab, Quantity: 10 mg/mL

可用日期:

Actor Pharmaceuticals Pty Ltd

药物剂型:

Injection, solution

组成:

Excipient Ingredients: water for injections; histidine hydrochloride monohydrate; trehalose dihydrate; polysorbate 20; histidine

给药途径:

Intravitreal-Within The Vitreous Cavity Of The Eye

每包单位数:

1 vial

处方类型:

(S4) Prescription Only Medicine

疗效迹象:

Raniviz (ranibizumab) is indicated in adults for:,? the treatment of neovascular (wet) age-related macular degeneration (AMD),,? the treatment of visual impairment due to diabetic macular oedema (DME),,? treatment of proliferative diabetic retinopathy (PDR),,? the treatment of visual impairment due to choroidal neovascularisation,,? the treatment of visual impairment due to choroidal neovascularisation (CNV) secondary to pathologic myopia (PM),,? the treatment of visual impairment due to macular oedema secondary to retinal vein occlusion (RVO).,Not recommended for use in preterm infants.

產品總結:

Visual Identification: Clear, colourless to pale yellow, aqueous solution, in a clear Type I glass vial, with a chlorobutyl stopper and an aluminium seal; Container Type: Vial; Container Material: Glass Type I Clear; Container Life Time: 36 Months; Container Temperature: Store at 2 to 8 degrees Celsius; Container Closure: Neither child resistant closure nor restricted flow insert

授权状态:

Registered